Validity and reliability of a self-reported measure of medication adherence in patients with Type2 diabetes mellitus in Singapore

Diabetic Medicine

Volumn 29, Issue 9, 2012, Pages

  Wang, Y ^a   Lee, J ^a   Toh, M P H S ^b   Tang, W E ^c   Ko, Y ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL HEALTHCARE GROUP   (Singapore)

^c NATIONAL HEALTHCARE GROUP POLYCLINICS   (Singapore)

Author keywords

Diabetes mellitus; Medication adherence; Morisky Green Levine Medication Adherence Scale

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CONSTRUCT VALIDITY; CONTENT VALIDITY; CROSS-SECTIONAL STUDY; DIET; EXERCISE; FACTORIAL ANALYSIS; FEMALE; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORISKY GREEN LEVINE MEDICATION ADHERENCE SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PATIENT COMPLIANCE; PSYCHOMETRY; RELIABILITY; SELF REPORT; SINGAPORE;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTPATIENTS; PATIENT COMPLIANCE; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SELF REPORT; SINGAPORE;

EID: 84865136427     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03733.x     Document Type: Article

References (35)

1. World Health Organization. Diabetes Fact Sheet. Available at http://www.who.int/mediacentre/factsheets/fs312/en/index.html Last accessed 25 July 2011.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
3. Singapore Ministry of Health. National Health Survey 2004 Main Report-Introduction and Diabetes Mellitus. Available at http://www.moh.gov.sg/mohcorp/publicationsreports.aspx?id=2984 Last accessed 13 July 2011.
4. Singapore Ministry of Health. The Electronic HealthScope 2008. Available at http://www.moh.gov.sg/HEALTHSCOPE/archive/jun08.pdf Last accessed 17 June 2011.
5. Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res 2005; 36: 300-306.
6. World Health Organization. Adherence to Long-term Therapies: Evidence for Action 2003. Available at http://whqlibdoc.who.int/publications/2003/9241545992.pdf Last accessed 17 June 2010.
7. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50years of research. Med Care 2004; 42: 200-209.
8. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218-1224.
9. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166: 1836-1841.
10. Breitscheidel L, Stamenitis S, Dippel FW, Schoffski O. Economic impact of compliance to treatment with antidiabetes medication in type2 diabetes mellitus: a review paper. J Med Econ 2010; 13: 8-15.
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497.
12. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331-342.
13. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
14. Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 2004; 38: 1363-1368.
15. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother 2001; 35: 997-1003.
16. Al-Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight-item Morisky Medication Adherence Scale (MMAS): translation and validation of the Malaysian version. Diabetes Res Clin Pract 2010; 90: 216-221.
17. Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type2 diabetes. Ann Pharmacother 2009; 43: 950-957.
18. Tzeng JI, Chang CC, Chang HJ, Lin CC. Assessing analgesic regimen adherence with the Morisky Medication Adherence Measure for Taiwanese patients with cancer pain. J Pain Symptom Manage 2008; 36: 157-166.
19. Bosworth HB, Dudley T, Olsen MK, Voils CI, Powers B, Goldstein MK et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med 2006; 119: 70.e9-70.e15.
20. Trivedi RB, Ayotte B, Edelman D, Bosworth HB. The association of emotional well-being and marital status with treatment adherence among patients with hypertension. J Behav Med 2008; 31: 489-497.
21. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42.
22. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995; 4: 293-307.
23. Cortina JM. What is coefficient alpha? An examination of theory and applications. J Appl Psychol 1993; 78: 98-104.
24. Donnelly LA, Morris AD, Evans JM. Adherence to insulin and its association with glycaemic control in patients with type2 diabetes. Q J Med 2007; 100: 345-350.
25. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002; 25: 1015-1021.
26. Diehl AK, Bauer RL, Sugarek NJ. Correlates of medication compliance in non-insulin-dependent diabetes mellitus. South Med J 1987; 80: 332-335.
27. Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM et al. Patient adherence improves glycemic control. Diabetes Educator 2005; 31: 240-250.
28. Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K et al. Medication adherence and associated hemoglobin A1c in type2 diabetes. Ann Pharmacother 2004; 38: 1357-1362.
29. Natarajan N, Putnam RW, Yip AM, Frail D. Family practice patients' adherence to statin medications. Can Fam Physician 2007; 53: 2144-2145.
30. Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol 2010; 63: 299-306.
31. Streiner DL, Norman GR. Scaling responses. In: Streiner DL, Norman GR, eds. Health Measurement Scales: A Practical Guide to their Development and Use, 1st edn. New York: Oxford University Press, 1989: 20-38.
32. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10: 348-354.
33. Meghani SH, Bruner DW. A pilot study to identify correlates of intentional versus unintentional nonadherence to analgesic treatment for cancer pain. Pain Manag Nurs; doi: 10.1016/j.pmn.2011.03.003 (in press).
34. Da Silva Carvalho AR, Dantas RA, Pelegrino FM, Corbi IS. Adaptation and validation of an oral anticoagulation measurement of treatment adherence instrument. Rev Lat Am Enfermagem 2010; 18: 301-308.
35. Berg KM, Wilson IB, Li X, Arnsten JH. Comparison of antiretroviral adherence questions. AIDS Behav 2012; 16: 461-468.